Guest guest Posted December 26, 2008 Report Share Posted December 26, 2008 Kristy, While I agree about the meds and the years of research, I do feel that the drug companies do some deceitful things, Like mixing two meds to make them seem different and getting a new patent so they can continue to gouge consumers who don't know better. Case in point- treximet is a mixture of the drug imitrex which is soon to be available in generic form and an Nsaid which is available without a prescription. It is a way to continue to rake in the big bucks on people who don't know better. I know a lady who paid a lot of money for sarafem (I think that is the spelling) for PMS. Her insurance wouldn't pay for it as a preferred brand. I told her it was plain old prozac and she could have gotten it for 5 dollars as a generic. she argued with me the she was allergic to prozac and was pissed when she found out through her pharmacist that I was right. Also years of lawsuits have made the system the way it is. From phen fen to vioxx, the drug companies have taken some hard hits. I know the avalanche of commercials wanting people to sue was overwhelming. The whole system is messed up and needs fixing. Mel In a message dated 12/27/2008 5:27:30 A.M. Central Standard Time, krisandkeith@... writes: it is important to note the many years that drug companies invest in research and development with no guarantee of success. The risks are high for them...if they did not make money then they wouldn't bother being in the business and we would miss out on the benefits of these drugs. The drug companies are not to blame...the government is. **************One site keeps you connected to all your email: AOL Mail, Gmail, and Yahoo Mail. Try it now. (http://www.aol.com/?optin=new-dp & icid=aolcom40vanity & ncid=emlcntaolcom00000025) Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.